HK Stock MarketDetailed Quotes

06826 HAOHAI BIOTEC

Watchlist
  • 42.000
  • +1.100+2.69%
Not Open May 2 16:08 CST
7.09BMarket Cap14.85P/E (TTM)

HAOHAI BIOTEC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
5.68%646M
25.27%2.63B
25.23%1.98B
36.54%1.31B
29.06%611.25M
20.19%2.1B
24.14%1.58B
13.05%956.27M
23.79%473.62M
32.14%1.75B
Operating income
5.68%646M
25.27%2.63B
25.23%1.98B
36.54%1.31B
29.06%611.25M
20.19%2.1B
24.14%1.58B
13.05%956.27M
23.79%473.62M
32.14%1.75B
Cost of sales
----
-19.02%-781.4M
----
-31.02%-379.29M
----
-33.88%-656.52M
----
-33.53%-289.48M
----
-46.82%-490.37M
Operating expenses
-14.13%-198.87M
-19.02%-781.4M
-18.58%-561.89M
-31.02%-379.29M
-11.54%-174.25M
-33.88%-656.52M
-44.30%-473.85M
-33.53%-289.48M
-61.87%-156.22M
-46.82%-490.37M
Gross profit
2.32%447.12M
28.10%1.85B
28.07%1.42B
38.94%926.42M
37.68%437M
14.86%1.45B
17.15%1.11B
5.99%666.78M
10.95%317.4M
27.19%1.26B
Selling expenses
0.51%-199.35M
-19.86%-814.51M
-25.71%-625.68M
-34.29%-420.95M
-35.33%-200.38M
-10.97%-679.53M
-19.40%-497.72M
-23.85%-313.46M
-21.25%-148.06M
-10.19%-612.34M
Administrative expenses
11.94%-82.47M
-4.20%-422.35M
3.33%-313.46M
7.36%-200.64M
-24.46%-93.65M
-41.67%-405.3M
-77.63%-324.26M
-97.08%-216.59M
-51.49%-75.24M
-31.99%-286.09M
Research and development expenses
-21.03%-64.9M
-20.81%-220.1M
-27.17%-154.15M
-32.17%-101.39M
-17.80%-53.62M
-8.71%-182.19M
-6.57%-121.22M
-4.39%-76.71M
-24.62%-45.52M
-32.51%-167.6M
Profit from asset sales
-9,233.48%-36.32K
----
2,281.76%518.61K
----
-100.69%-389.15
----
-132.74%-23.77K
----
842.65%56K
----
Revaluation surplus
-182.99%-461.1K
----
192.38%2.15M
----
--555.64K
----
---2.33M
----
----
----
-Changes in the fair value of other assets
-182.99%-461.1K
----
192.38%2.15M
----
--555.64K
----
---2.33M
----
----
----
Impairment and provision
103.74%89.04K
112.72%1.97M
78.95%-7.57M
46.67%-4.59M
-97.81%-2.38M
-587.62%-15.52M
-1,964.28%-35.94M
-193.83%-8.62M
22.15%-1.2M
132.43%3.18M
-Other impairment is provision
103.74%89.04K
112.72%1.97M
78.95%-7.57M
46.67%-4.59M
-97.81%-2.38M
-587.62%-15.52M
-1,964.28%-35.94M
-193.83%-8.62M
22.15%-1.2M
132.43%3.18M
Operating interest expense
----
4.05%-7.3M
----
-42.77%-3.67M
----
-53.19%-7.6M
----
-60.55%-2.57M
----
-1.18%-4.96M
Special items of operating profit
-63.44%3.87M
54.51%116.57M
-17.33%28.09M
15.32%54.29M
158.75%10.58M
-59.98%75.45M
-44.84%33.98M
-45.31%47.08M
-77.90%4.09M
11.40%188.52M
Operating profit
5.05%100.66M
118.67%507.8M
124.27%340.65M
160.07%249.47M
96.90%95.82M
-38.96%232.22M
-47.41%151.89M
-65.01%95.93M
-47.55%48.67M
47.95%380.46M
Financing cost
-10.87%13.76M
----
-17.57%47.95M
----
-26.29%15.44M
----
-13.77%58.17M
----
-4.85%20.95M
----
Share of profits of associates
----
51.50%456K
----
115.89%326K
----
223.66%301K
----
26.89%151K
----
170.99%93K
Share of profit from joint venture company
----
----
----
----
----
52.57%3.2M
----
--1.35M
----
--2.1M
Special items of earning before tax
-131.68%-262.85K
----
235.88%746.12K
----
340.12%829.76K
----
15.30%-549.11K
----
298.33%188.53K
----
Earning before tax
1.85%114.16M
115.61%508.26M
85.84%389.35M
156.39%249.8M
60.58%112.1M
-38.40%235.73M
-41.09%209.51M
-64.48%97.43M
-39.15%69.81M
48.88%382.65M
Tax
20.14%-21.68M
-111.46%-95.99M
-44.23%-62.38M
-76.16%-41.11M
-328.86%-27.14M
-28.36%-45.4M
-4.48%-43.25M
37.49%-23.34M
58.91%-6.33M
-15.25%-35.37M
After-tax profit from continuing operations
8.87%92.49M
116.61%412.27M
96.66%326.97M
181.67%208.69M
33.83%84.95M
-45.19%190.33M
-47.09%166.26M
-68.73%74.09M
-36.09%63.48M
53.43%347.28M
Earning after tax
8.87%92.49M
116.61%412.27M
96.66%326.97M
181.67%208.69M
33.83%84.95M
-45.19%190.33M
-47.09%166.26M
-68.73%74.09M
-36.09%63.48M
53.43%347.28M
Minority profit
-233.88%-5.05M
-139.06%-3.85M
-96.35%164.45K
12.81%3.45M
48.85%3.77M
299.17%9.86M
20.77%4.51M
-48.25%3.06M
9.18%2.54M
-32.66%-4.95M
Profit attributable to shareholders
20.16%97.54M
130.58%416.12M
102.04%326.8M
188.94%205.24M
33.21%81.18M
-48.76%180.47M
-47.91%161.75M
-69.25%71.03M
-37.17%60.94M
53.10%352.23M
Basic earnings per share
23.40%0.58
134.62%2.44
105.38%1.91
192.68%1.2
34.29%0.47
-48.00%1.04
-47.16%0.93
-68.70%0.41
-36.36%0.35
53.85%2
Diluted earnings per share
23.40%0.58
134.62%2.44
105.38%1.91
192.68%1.2
34.29%0.47
-48.00%1.04
-47.16%0.93
-68.70%0.41
-36.36%0.35
53.85%2
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover 5.68%646M25.27%2.63B25.23%1.98B36.54%1.31B29.06%611.25M20.19%2.1B24.14%1.58B13.05%956.27M23.79%473.62M32.14%1.75B
Operating income 5.68%646M25.27%2.63B25.23%1.98B36.54%1.31B29.06%611.25M20.19%2.1B24.14%1.58B13.05%956.27M23.79%473.62M32.14%1.75B
Cost of sales -----19.02%-781.4M-----31.02%-379.29M-----33.88%-656.52M-----33.53%-289.48M-----46.82%-490.37M
Operating expenses -14.13%-198.87M-19.02%-781.4M-18.58%-561.89M-31.02%-379.29M-11.54%-174.25M-33.88%-656.52M-44.30%-473.85M-33.53%-289.48M-61.87%-156.22M-46.82%-490.37M
Gross profit 2.32%447.12M28.10%1.85B28.07%1.42B38.94%926.42M37.68%437M14.86%1.45B17.15%1.11B5.99%666.78M10.95%317.4M27.19%1.26B
Selling expenses 0.51%-199.35M-19.86%-814.51M-25.71%-625.68M-34.29%-420.95M-35.33%-200.38M-10.97%-679.53M-19.40%-497.72M-23.85%-313.46M-21.25%-148.06M-10.19%-612.34M
Administrative expenses 11.94%-82.47M-4.20%-422.35M3.33%-313.46M7.36%-200.64M-24.46%-93.65M-41.67%-405.3M-77.63%-324.26M-97.08%-216.59M-51.49%-75.24M-31.99%-286.09M
Research and development expenses -21.03%-64.9M-20.81%-220.1M-27.17%-154.15M-32.17%-101.39M-17.80%-53.62M-8.71%-182.19M-6.57%-121.22M-4.39%-76.71M-24.62%-45.52M-32.51%-167.6M
Profit from asset sales -9,233.48%-36.32K----2,281.76%518.61K-----100.69%-389.15-----132.74%-23.77K----842.65%56K----
Revaluation surplus -182.99%-461.1K----192.38%2.15M------555.64K-------2.33M------------
-Changes in the fair value of other assets -182.99%-461.1K----192.38%2.15M------555.64K-------2.33M------------
Impairment and provision 103.74%89.04K112.72%1.97M78.95%-7.57M46.67%-4.59M-97.81%-2.38M-587.62%-15.52M-1,964.28%-35.94M-193.83%-8.62M22.15%-1.2M132.43%3.18M
-Other impairment is provision 103.74%89.04K112.72%1.97M78.95%-7.57M46.67%-4.59M-97.81%-2.38M-587.62%-15.52M-1,964.28%-35.94M-193.83%-8.62M22.15%-1.2M132.43%3.18M
Operating interest expense ----4.05%-7.3M-----42.77%-3.67M-----53.19%-7.6M-----60.55%-2.57M-----1.18%-4.96M
Special items of operating profit -63.44%3.87M54.51%116.57M-17.33%28.09M15.32%54.29M158.75%10.58M-59.98%75.45M-44.84%33.98M-45.31%47.08M-77.90%4.09M11.40%188.52M
Operating profit 5.05%100.66M118.67%507.8M124.27%340.65M160.07%249.47M96.90%95.82M-38.96%232.22M-47.41%151.89M-65.01%95.93M-47.55%48.67M47.95%380.46M
Financing cost -10.87%13.76M-----17.57%47.95M-----26.29%15.44M-----13.77%58.17M-----4.85%20.95M----
Share of profits of associates ----51.50%456K----115.89%326K----223.66%301K----26.89%151K----170.99%93K
Share of profit from joint venture company --------------------52.57%3.2M------1.35M------2.1M
Special items of earning before tax -131.68%-262.85K----235.88%746.12K----340.12%829.76K----15.30%-549.11K----298.33%188.53K----
Earning before tax 1.85%114.16M115.61%508.26M85.84%389.35M156.39%249.8M60.58%112.1M-38.40%235.73M-41.09%209.51M-64.48%97.43M-39.15%69.81M48.88%382.65M
Tax 20.14%-21.68M-111.46%-95.99M-44.23%-62.38M-76.16%-41.11M-328.86%-27.14M-28.36%-45.4M-4.48%-43.25M37.49%-23.34M58.91%-6.33M-15.25%-35.37M
After-tax profit from continuing operations 8.87%92.49M116.61%412.27M96.66%326.97M181.67%208.69M33.83%84.95M-45.19%190.33M-47.09%166.26M-68.73%74.09M-36.09%63.48M53.43%347.28M
Earning after tax 8.87%92.49M116.61%412.27M96.66%326.97M181.67%208.69M33.83%84.95M-45.19%190.33M-47.09%166.26M-68.73%74.09M-36.09%63.48M53.43%347.28M
Minority profit -233.88%-5.05M-139.06%-3.85M-96.35%164.45K12.81%3.45M48.85%3.77M299.17%9.86M20.77%4.51M-48.25%3.06M9.18%2.54M-32.66%-4.95M
Profit attributable to shareholders 20.16%97.54M130.58%416.12M102.04%326.8M188.94%205.24M33.21%81.18M-48.76%180.47M-47.91%161.75M-69.25%71.03M-37.17%60.94M53.10%352.23M
Basic earnings per share 23.40%0.58134.62%2.44105.38%1.91192.68%1.234.29%0.47-48.00%1.04-47.16%0.93-68.70%0.41-36.36%0.3553.85%2
Diluted earnings per share 23.40%0.58134.62%2.44105.38%1.91192.68%1.234.29%0.47-48.00%1.04-47.16%0.93-68.70%0.41-36.36%0.3553.85%2
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg